Management of Type 2 diabetes in Ramadan: Low-ratio premix insulin working group practical advice

The challenge of insulin use during Ramadan could be minimized, if people with diabetes are metabolically stable and are provided with structured education for at least 2–3 months pre-Ramadan. Although, American diabetes association (ADA) recommendations 2010 and South Asian Consensus Guideline 2012...

Descripción completa

Detalles Bibliográficos
Autores principales: Hassanein, Mohamed, Belhadj, Mohamed, Abdallah, Khalifa, Bhattacharya, Arpan D., Singh, Awadhesh K., Tayeb, Khaled, Al-Arouj, Monira, Elghweiry, Awad, Iraqi, Hinde, Nazeer, Mohamed, Jamoussi, Henda, Mnif, Mouna, Al-Madani, Abdulrazzaq, Al-Ali, Hossam, Ligthelm, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2014
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4192983/
https://www.ncbi.nlm.nih.gov/pubmed/25364673
http://dx.doi.org/10.4103/2230-8210.140242
Descripción
Sumario:The challenge of insulin use during Ramadan could be minimized, if people with diabetes are metabolically stable and are provided with structured education for at least 2–3 months pre-Ramadan. Although, American diabetes association (ADA) recommendations 2010 and South Asian Consensus Guideline 2012 deal with management of diabetes in Ramadan and changes in insulin dosage, no specific guidance on widely prescribed low-ratio premix insulin is currently available. Hence, the working group for insulin therapy in Ramadan, after collective analysis, evaluation, and opinion from clinical practice, have formulated a practical advice to empower physicians with pre-Ramadan preparation, dose adjustment, and treatment algorithm for self-titration of low-ratio premix insulin.

Ejemplares similares